Thomas Hutton - Chemed VP Director

CXM Stock  EUR 545.00  5.00  0.91%   

Insider

Thomas Hutton is VP Director of Chemed
Age 72
Phone513 762 6690
Webhttps://www.chemed.com

Thomas Hutton Latest Insider Activity

Tracking and analyzing the buying and selling activities of Thomas Hutton against Chemed stock is an integral part of due diligence when investing in Chemed. Thomas Hutton insider activity provides valuable insight into whether Chemed is net buyers or sellers over its current business cycle. Note, Chemed insiders must abide by specific rules, including filing SEC forms every time they buy or sell Chemed'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Chemed Management Efficiency

The company has return on total asset (ROA) of 0.1558 % which means that it generated a profit of $0.1558 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.3511 %, meaning that it generated $0.3511 on every $100 dollars invested by stockholders. Chemed's management efficiency ratios could be used to measure how well Chemed manages its routine affairs as well as how well it operates its assets and liabilities.
Chemed has accumulated 92.5 M in total debt with debt to equity ratio (D/E) of 30.1, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Chemed has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Chemed until it has trouble settling it off, either with new capital or with free cash flow. So, Chemed's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Chemed sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Chemed to invest in growth at high rates of return. When we think about Chemed's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Ikusuke ShimizuSekisui Chemical Co
59
Katsunori MukaiSekisui Chemical Co
N/A
Andy HancockMoneysupermarket Group PLC
N/A
Timothy JonesMoneysupermarket Group PLC
52
Keita KatoSekisui Chemical Co
65
Kazuya MurakamiSekisui Chemical Co
57
Naoko FukutomiSekisui Chemical Co
N/A
Toshiyuki KamiyoshiSekisui Chemical Co
62
Tatsuya NishidaSekisui Chemical Co
N/A
Futoshi KamiwakiSekisui Chemical Co
63
Sian GrieveMoneysupermarket Group PLC
N/A
Nigel PocklingtonMoneysupermarket Group PLC
51
Alvaro AguilarMoneysupermarket Group PLC
N/A
Alex WilliamsonMoneysupermarket Group PLC
N/A
Peter DuffyMoneysupermarket Group PLC
57
Shazadi StintonMoneysupermarket Group PLC
N/A
Scilla GrimbleMoneysupermarket Group PLC
N/A
Meiko KogaSekisui Chemical Co
N/A
Yoshiyuki HiraiSekisui Chemical Co
60
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. Chemed Corporation was founded in 1970 and is headquartered in Cincinnati, Ohio. CHEMED CORP operates under Medical Care classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15707 people. Chemed (CXM) is traded on Frankfurt Exchange in Germany and employs 14,167 people.

Management Performance

Chemed Leadership Team

Elected by the shareholders, the Chemed's board of directors comprises two types of representatives: Chemed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemed. The board's role is to monitor Chemed's management team and ensure that shareholders' interests are well served. Chemed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemed's outside directors are responsible for providing unbiased perspectives on the board's policies.
Thomas Hutton, VP Director
Nicholas Westfall, Ex VP
David Williams, Ex CFO
Kevin McNamara, Pres CEO
Sherri Warner, Director Relations
Lisa Reinhard, Chief VP
Brian Judkins, S VP

Chemed Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Chemed Stock

Chemed financial ratios help investors to determine whether Chemed Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Chemed with respect to the benefits of owning Chemed security.